Skip to main content
Screener/Healthcare/Biotechnology

KROS — Keros Therapeutics, Inc.

NASDAQ
$11.99+0.35 (+3.05%)
Small CapUnder $20Healthcare
$10.42
$22.55
$11.38
$11.99
EPS (TTM)$2.30
P/E Ratio5.22
Dividend Yield—
Market Cap$435.9M
Volume241K
Prev Close$11.64
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$385K-$23.5M$-0.38-3.9%-6093.8%
Q3 '25$14.3M-$7.3M$-0.1897.2%-51.0%
Q2 '25$18.2M-$30.7M$-0.7698.0%-169.0%
Q1 '25$211.2M$148.5M$3.62100.0%70.3%
Q4 '24$3.0M-$46.0M$-1.1489.1%-1513.0%
Q3 '24$388K-$53.0M$-1.4719.1%-13648.5%
Q2 '24$37K-$45.3M$-1.25100.0%-122316.2%
Q1 '24$83K-$43.1M$-1.46100.0%-51944.6%
Get Your Daily Market Recap